Our results indicated that SATB2-AS1 could negatively regulate miR-155-3p in BC development, and the overexpression of SATB2-AS1 or down-regulation of miR-155-3p may suppress the malignant phenotypes of BC cells by promoting BRMS1L, thereby decelerating the progression of BC. Here, BRMS1L is linked to breast cancer.